# aTYR PHARMA INC: Form 8-K, filed Aug 7, 2025

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 16:03 ET
- Period: 2025-08-07
- Accession: 0001339970-25-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000133997025000007/atyr-20250807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000133997025000007/

## Items reported

- Item 2.06: Material impairments
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000133997025000007/atyr-20250807.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001339970-25-000007. Last ingested by Listed: Nov 6, 2026, 16:47 ET. No prices; not investment advice.